Table 2. Clinical characteristics of HMPV-positive patients compared with RSV-positive patients and the rest of the study cohort, New Vaccine Surveillance Network acute respiratory illness study, August 2000–September 2001.
| HMPV-positive, n = 26 | RSV-positive, n = 125 | Rest of cohort, n = 517 | |
|---|---|---|---|
| Characteristic |
n (%) |
n (%) |
n (%) |
| Presenting Symptoms |
|
|
|
| Cough |
24 (92)a,b |
124 (99) |
333 (64) |
| Fever |
19 (73) |
85 (68) |
383 (74) |
| Nasal Congestion |
20 (77) |
110 (88) |
329 (64) |
| Shortness of Breath |
21 (81) |
119 (95) |
334 (65) |
| Hospital Course |
|
|
|
| Admitted to ICU |
4 (15) |
6 ( 5) |
28 ( 5) |
| Received supplemental O2 |
14 (54)a,c |
76(61) |
51 (29) |
| Intubated |
2 ( 8) |
3 (2) |
10 (2) |
| Chest x-ray findings |
(n = 23) |
(n = 105) |
(n = 304) |
| Chest x-ray performed |
23 (88)a,c |
105 (84) |
304 (59) |
| Any pneumonia/infiltration |
9 (39) |
25 (23) |
77 (25) |
| Hyperinflation | 11 (48) | 54 (51) | 103 (34) |
aComparison of HMPV-positive patients to rest of cohort. bp<0.001. cp<0.01